Is melatonin deficiency a unifying pathomechanism of high risk patients with COVID-19?

Life Sci. 2020 Sep 1:256:117902. doi: 10.1016/j.lfs.2020.117902. Epub 2020 Jun 3.

Authors

Fedor Simko¹, Russel J Reiter²

Affiliations

¹ Institute of Pathophysiology, Faculty of Medicine, Comenius University, Sasinkova 4, 811 08 Bratislava, Slovak Republic; Institute of Experimental Endocrinology, Biomedical Research Center, Slovak Academy of Sciences, Bratislava, Slovak Republic. Electronic address: simko@fmed.uniba.sk.
² Department of Cell Systems and Anatomy, UT Health San Antonio, San Antonio, TX, USA.

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Review
Comment

MeSH terms

Betacoronavirus*
COVID-19
Coronavirus Infections*
Humans
Melatonin*
Pandemics*
Pneumonia, Viral*
SARS-CoV-2

Substances

Melatonin